Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER‐1, UNCOVER‐2 and UNCOVER‐3)
A. Menter; R.B. Warren; R.G. Langley; J.F. Merola; L.N. Kerr; E.B. Dennehy; D. Shrom; D. Amato; Y. Okubo; K. Reich
Author Information: Baylor University Medical Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.